Improvement of embryo quality during in-vitro culture can be achieved by understanding and controlling the requirements of gametes and embryos. The most obvious route is to alter culture media, but standardization could be influenced by diverse environmental factors. Abnormal embryos from patients with multiple failures probably do not benefit from standardization and require specialized therapy, that is if their physiology is not already irreversibly jeopardized during gametogenesis. This paper describes the adverse environmental factors present in laboratory air and released by common products used by laboratories. Assays and results of the air determinations in several laboratories are reported, as well as potential counter measures. The possibility of altering the immediate environment of the nucleus of the egg by ooplasmic transplantation is also considered, and the first attempts resulting in two ongoing pregnancies are reported.
Introduction
Human embryo quality control relies on inadequate technology, since there are no absolute laboratory criteria to predict implantation of vital embryos. Assays of embryo development include interesting work on numerical chromosomal analysis of oocytes and embryos, gene products such as the housekeeping and metabolic genes, growth factor cytokines and other matters. Here we will discuss the potential improvement of embryo quality with the emphasis on the organic chemistry of laboratory air and its potential adverse effects on embryos. Secondly, efforts to enhance development by ooplasmic transfer into oocytes will be presented, since this has been of considerable interest to our team.
Laboratory environment
There is very little literature about the potential effects of polluted air on human oocytes and embryos. It is, therefore, a relatively crude field of study in the sense that there is no apparent reference list. We became interested in it after two particular incidents led us to conclude that we should study the organic composition of laboratory and incubator air. The first incident occurred as our laboratory moved to a new facility. Such a mass move, of course, is usually accompanied by some paranoia. We already had some evidence that poor air and construction could influence implantation rates. Another important factor in our decision to study the laboratory environment involved advances made over the last few years by ambient air organic chemists. They have been able to develop assays in which volatile organic compounds can be measured in jig/m 3 rather than mg/m 3 which used to be the case. Assay systems have become much more sensitive, and they can detect two or three molecules in a small volume of space. These organic chemists can investigate specialized environments, by sampling a volume of air with a vacuum capture system and a flow restrictor and then analyse the captured air. This is mostly done using chromatography after liquid nitrogen purging, when everything in the captured air is solidified.
We decided to use gas chromatography and then mass spectrophotometry to determine the levels of volatile organic compounds (VOCs), in our laboratory. Assays for chemical air contamination (CAC) can qualify products absorbed by, e.g. activated carbon or potassium permanganate which is an oxidizer used mostly in museums to remove VOCs. Assessments of organic and inorganic compounds can also be done using other detection methods. Various situations can be measured, e.g. emissions from plastics or any small or large equipment item. These methods can determine the nature of the off-gassing or out-gassing emissions from such products. The composition of laboratory air is, of course, affected by such emissions.
After we moved to our new laboratory, our implantation rates reached our previous good levels. Then two incidents occurred that gave us concern. We usually check overall pregnancy rates retrospectively by examining results at intervals from 20 or 30 patients. Two very clear periods were identified, with significant decreases in implantation rates. One occurred 2 years ago, the other more recently. Results during these periods were significantly lower than during any other period. On each occasion, we checked for batch differences between products, technician efficiency, results of different physicians, variations in batches of culture medium and other items, but we could not determine the cause of the fluctuations.
It was determined retrospectively that two variations in air handling had caused these downturns. In October 1995, an unusual incident in the environment occurred in New Jersey, involving an infestation of ladybugs (ladybirds). When our first ladybug appeared, we were not concerned because everyone thinks they bring good luck. Then they came in thousands and millions, and hovered around the building. They were visible in the light receptacles although very rarely gained access into the laboratory because it is an isolated area. There were millions around the building, and any coming into our space were picked up, squeezed gently and then put into a jar for disposal. However, this means of disposal is not the American way! Administrators in the building decided to use pesticides instead. We thought we had informed most people in the building that this step should not be taken, but we realized that we were probably already too late. Three incidents of fumigation occurred, using pesticides in the building, and by examining the purchase orders, we could determine the dates. Implantation rates significantly diminished after each fumigation. Interestingly, development in vitro and fertilization appeared to be normal. The second decrease in pregnancy rates was also the result of air handling issues: the filter systems became saturated earlier than anticipated. This problem was easily resolved by changing the filters.
The sources of chemical air contamination are many and varied. Industrial sources include car exhausts. These contaminants may be identified, since some products are specific to car emissions. Such emissions rarely penetrate into laboratories, and have not occurred in the five laboratories we have examined so far. Usually, this form of contamination only affects laboratories without overpressure or when a truck or car parks underneath the inlet of the air handling system. Other important contaminants are released from adhesives, packaging, insulation, paints, plastic wear and of course laboratory equipment, to produce very high emissions in the immediate environment. Many embryologists feel that they have resolved the problem of air contamination if a HEPA filtration system is installed, but this form of filtration is basically just a large sieve; it sifts out dust, other particles and microbial organisms but anything else, inorganic or organic, passes through, since it is not designed to remove such compounds. There are large pores in such filters, and any existing molecules can pass through the sieves, small and large. Minor amounts of passive residual adhesions may occur after the air is pumped through the sieve system.
Incubators may have even worse air than laboratory air. Virtually 95% of incubator air is the same as the laboratory air, since there is no purge during incubator opening, but the temperatures are elevated and humidity is increased. The remaining 5% of air comes from an unchecked metal bottle containing CO 2 . These metal bottles are filthy on the outside; we always presumed they were cleaner inside, but after sampling the contents, it was obvious that they were not. There are, of course, systems of embryo and oocyte culture where 100% of the gas phase comes from such bottles, but this may make matters even worse. Bottles certified as high medical grade were assayed as well, with similar results. A small device built into the incubator sampled air over a 24 h period. Low levels of volatile organic compounds were found in the older incubators but incredibly high levels were found in the new incubators.
Compressed CO 2 bottles are another source of contamination. We have tested about 10 bottles so far and found up to 60 different VOCs in them, the most obvious being benzene. Refrigeration agents and isopropyl alcohol were also commonly present in high quantities. Some bottles were fairly clean, indicating that gametes and embryos from different incubators are cultured in different environments.
Different areas in the laboratory were also measured. Refrigerants were everywhere, in the incubator and elsewhere, coming from heating, ventilation and air conditioning (HVAC) systems, refrigerators, and pieces of equipment which use freons. Hydrocarbon levels displayed a similar profile. Isopropyl alcohol comes from areas outside the laboratory, in spite of the use of overpressure. It was not noticeable in the incubator air because it enters the water pan. It dissolved in liquids and was thus removed from the air. Culture medium is another possible site where isopropyl alcohol may accumulate.
Modern technology can trace certain contaminants specific to the laboratory environment. In our case, a leak of anaesthetic gas, called enflurane, entered somewhere else in the building and was found mostly in the hallways. However, since the level was below Occupational Safety and Health Authority (OSHA) standards, our institution was not required to do anything about it.
Levels of VOCs such as benzene, toluene, cyclenes and styrene should also be assayed. Levels can be high in incubators because of the items placed in them, especially plastics. Styrene comes from Petri dishes or other materials used for sterile culture. Some manufacturers are worse offenders than others, mostly due to the way the plastic items are packaged. If the package is completely heat sealed, without a breathable sleeve, the gasses from those packages are much more offensive in terms of VOCs than other plastic items wrapped in breathable sheets or sleeves. Out-gassing cannot occur in a closed envelope. This can arise with any type of sterile plastic when used in culture, so the contents should be out-gassed for a few days, although of course this may jeopardize sterility. We concluded that plastic items are the sources of styrene, toluene and some of the cyclenes. Benzene is more specifically derived from gas bottles and its level is elevated in incubators, but declines according to the distance from them. None of these products were tested with embryos, and this probably needs to be done in the future. The weakness of our determinations is that we do not know the effect benzene has on embryos, even animal embryos What can be done about chemical air contamination. Problems concerning plastic items can be discussed with manufacturers, or out-gassing can be carried out in a specialized environment. CO 2 is a much more difficult issue, involving compressed air. The manufacturer may need to be consulted. In a few cases, laboratories have had to be reconstructed or renovated. In two incidences, laboratories were relocated because the new laboratories were basically toxic; in one case this was due to insulation material which was out-gassing continuously. An HVAC system and air handling system could be designed to contain absorption material, such as activated carbon. This would be placed before the HEPA filtration in the air handling system to remove adverse absorption material which can be released into the laboratory air as dust.
Alternative culture systems could ionize the air initially, but this would not help matters a great deal. Solid media filtration is used in our laboratory in two areas, mostly using activated carbon. Many different forms of activated carbon are available, and the right one must be used. It can be placed in the central HVAC system, if it is powerful enough. Tower units (GenX, CT, USA) are now available, using activated carbon and potassium permanganate, which will remove many VOCs. These can be placed in different areas of the laboratory. Incubator filter units (Coda, GenX) can be installed, which contain activated carbon and which are made from materials which are unlikely to affect embryos. Specific filters can be used for specific gases coming from compressed gas cylinders. VOCs can be reduced using uniquely designed small filtration systems. I would like to conclude this section by stressing that no controlled trials have been done to test the effects of these agents, although we have carried out some preliminary trials in the mouse (Cohen et ai, 1997) .
Ooplasmic transfer into human oocytes and eggs
The second subject for discussion is the transfer of cytoplasm into oocytes and eggs, a concept described in the literature in various publications over the last 10 years (see Cohen et ah, 1998) . Cytoplasmic transfer can potentially be performed at any stage up to genomic activation, into germinal vesicle (GV) oocytes, oocytes at the metaphase I (MI) or at Mil stages, into zygotes, or into 2-cell embryos. The most important step may be to transfer cytoplasm at the GV stages, with the potential aim of avoiding aneploidy or repairing any anomalies which occur later. The GV will, of course begin to mature in vitro, if it is not inhibited, so the transfer may be too late to be effective. It would be worthwhile to investigate the transfer of a GV nucleus from an oocyte of an older patient into the oocyte of a younger donor, to discover whether the rate of aneuploidy is reduced in young ooplasm.
We have been trying to improve the quality of human oocytes by donating ooplasm from another oocyte. The approach could be effective in various ways. It could involve contributing mRNA, specific transcripts, mitochondria, skeletal elements or cell cycle regulating factors.
Ooplasmic transfer using GV ooplasm electrofused to mouse zygotes caused various problems, which was not surprising. Synchronous transfers, from zygote to zygote, produced good development and implantation rates. Transfers of Mil cytoplasm to the zygote produced normal blastocyst formation in vitro and satisfactory rates of implantation (Levron et al, 1995) . Rates were 20% higher per embryo after ooplasmic donation, compared with controls. A significant reduction in fetal development was worrying, when we performed synchronous transfers, indicating that electrofusion may inhibit development. The possibility of toxicity during electrofusion has not been clarified, despite the large number of publications on nuclear transplantation in animals.
Clinical work started ~2 years ago. The Mil stage was chosen for the recipient since it is obviously much better to transfer as early as possible in development, provided that good success rates are guaranteed in the control groups. The GV stage would have been preferable, but this approach is limited by the problems of maturation in . vitro. A parallel exchange of ooplasm was done, using synchronous cytoplasm from donor eggs which were also at the Mil stage.
The study was carried out in six patients, over seven cycles. Our internal review board insisted on the use of two controls. Donors had to be selected with sufficient numbers of oocytes to carry out normal egg donation, i.e. not involving ooplasmic transfer. Secondly, if some eggs were not used, they had to be fertilized using the husband's spermatozoa and any embryos had to be cryopreserved for later use. Internal controls such as these, enabled us to measure the growth of non-injected embryos. Historical records of the patients' embryos showed all but one of them suffered from poor embryo development.
The patients selected were candidates for egg donation, having exhausted any other possible treatment. Ooplasmic transfer to the recipient oocytes was done prior to intracytoplasmic sperm injection (ICSI), because this manipulation activates almost all of the eggs at the Mil stage. Standard ICSI was performed after ooplasmic transfer, and co-cultures were used on all the patients, in case it was beneficial.
The polar body was removed from donor eggs via a large slit made in the zona pellucida. This slit helped to remove a donor ooplast from an area opposite the polar body, i.e. opposite the presumed position of the metaphase spindle. Sometimes, two or three ooplasts were excised, and the intact remainder of the egg was sent for cytogenetic analysis to ensure that the metaphase plate was present. In all the eggs examined, the metaphase spindle was adjacent to the polar body. The cytoplast was placed underneath the zona pellucida adjacent to the oolemma of the recipient oocyte. Fusion was accomplished within 1 h of applying the electrical pulse, and ICSI was performed during that period.
A total of 22 eggs were studied, and 21 of them fused with the ooplast. Some of these zygotes had very small or very large pronuclei; an appearance reminiscent of that occurring after spermatid injections into oocytes. Other pronuclei looked normal. Ten embryos were transferred, but no pregnancies resulted. None of the embryos looked any better than the best embryos previously obtained from these patients during previous cycles in our programme.
A modified protocol was introduced, which involved ooplasm donation by injection. It is probably the most simple route to deliver foreign ooplasm. A spermatozoon is drawn into the injection pipette, because ICSI has to be carried out anyway, and the spermatozoon provides a marker of the amount of ooplasm aspirated. In comparison with electrofusion, this method has limitations; the former method offers the opportunity of almost limitless amounts of ooplasm for transfer. The limit to this form of transfer is the transfer of the metaphase plate into the enucleated ooplasm of a donor egg. With the modified injection method, the limit is determined by the amount of ooplasm that can be injected, while keeping the egg intact. The recipient egg is transformed into a hybrid, where the minority of the ooplasm is derived from the donor. We have carried out this procedure in four patients.
The polar body in the donor egg was adjacent to the needle, which was inserted in order to sample ooplasm at the opposite pole. Ooplasm can be sampled from several areas opposite the polar body. The donor oocyte is treated more vigorously than normal during ICSI. Its membrane must be broken and lengthened carefully, a method described by Nagy et al. (1995) . When it is broken, ooplasm is sucked into the pipette, a distance of 500-1000 |im; this corresponds to 5-15% of the ooplasmic volume. Ooplasm can be seen entering the pipette, but the ooplasm skeleton can be obstructive, so the pipette may have to be moved several times. The membrane must be kept fluid and intact.
The recipient oocyte is in the same dish. Two witnesses stand by to avoid mistaking any of the eggs which are clearly identified on the dishes. Once again, the membrane must be broken and not by aspiration. Some ooplasm is aspirated after breakage to create room for injection. The spermatozoon can be seen entering the oocyte, which signifies the end of the injection.
These procedures were performed in four patients. Each had had a problem with implantation failure during a total of 17 previous cycles. They each had different causes of infertility, and after exhaustive assisted reproduction cycles, they always produced poor embryos. In all, 57 embryos had been transferred in all cycles combined in these four patients. The mean fragmentation rates of their replaced embryos (the best embryos) was 18-25% , and the development rate of the embryos was severely affected. They were synchronized with four donors. Internal egg donation controls were used in most of these cases. Ooplasmic injection was carried out during ICSI in all four cases and co-culture was used in three out of the four patients.
DNA staining of the remainder of the donor egg was done blindly. All donor oocytes had a metaphase and we were certain that no chromosomes from the donor egg were injected. Ooplasmic freezing would be beneficial, since it should be more economical than the present procedures, which are expensive and difficult to control, since two cycles of follicle stimulation are performed for one embryo transfer.
Two pronuclei formed in 27 out of 42 of the recipient oocytes. Aberrations of pronucleus development were clearly reduced, compared with the previous experiment, although nine embryos had one or unclear or uneven pronucleus. Of the embryos, 28 cleaved in co-culture, including one embryo which had a single large pronucleus. A total of one, four, four, and five embryos were replaced in these four patients.
In case number 1, i.e. the patient receiving one embryo, it became clear in retrospect that she had not been selected accurately, since her husband's spermatozoa were the cause of the poor embryo development. He had male factor infertility and always needed ICSI, although enough spermatozoa with normal morphology could be selected for injection. Spare donor eggs, which were fertilized with this man's spermatozoa using ICSI, also developed poorly and resembled embryos from previous cycles using his partner's own eggs. Only one donor embryo was transferred and none of the ooplasmic donor embryo or internal controls were transferred; these basically fell apart in fragments.
The other three patients did well. Six of the eight embryos obtained in the second case were better than control embryos and all historical records combined. After cytoplasmic injection, this patient became pregnant; there was one fetal heart beat and a baby girl was born with a good birth weight at 40 weeks' gestation. Her mother was 39.5 years old at the time of the treatment and was a little over 40 years when she delivered.
In the third case, four out of the five embryos again looked better than the controls and historical records. The patient became pregnant and her human chorionic gonadotrophin (HCG) concentrations were within normal parameters; however, she miscarried very early in pregnancy. In the fourth case, an internal control could not be used because of the limited number of eggs available. This patient was always a poor responder. One of the injected embryos was better than historical records. The patient became pregnant with one fetal heartbeat, and the pregnancy is ongoing.
In conclusion, we do not have analytical tools to assess whether these were appropriate patients or whether ooplasmic transfer is effective. Nor do we have any diagnostic or cytoplasmic diagnostic tests (other than morphological observation) available at the moment to assay oocytes and embryos. If donation is suggested, aneuploidy diagnosis in previous cycles may be necessary. The optimum method may be cytoplasmic injection, although electrofusion may still be preferable. More work on animal models is needed to determine any toxicity and whether volumetric changes in the oocyte are important. The removal and addition of ooplasm requires further analysis. Activation effects are important and especially the expansion of the pronuclei. The optimal stage is likely to be the GV stage, or at least very early in maturation.
Two different laboratories have done DNA fingerprinting and mitochondrial fingerprinting in amniocytes from the first pregnancy. These were combined with assays for both parents and the donor. No mitochondrial markers from the donor were found; DNA tests revealed that the child arose from both her parents, with no chromosomes coming from the donor.
